Innovating Works

LABORATORIOS ALPHA SAN IGNACIOP PHARMA

Inactiva
SILENSE: (Ultra)Sound Interfaces and Low Energy iNtegrated SEnsors NXP SEMICONDUCTORS BELGIUM NV tramitó un H2020: The SILENSE project will focus on using smart acoustic technologies and ultrasound in particular for Human Machine- and Machine to Machine Interfaces. Acoustic technologies have the main advantage of...
2017-05-01 | Financiado
PNEUMOSIP: PNEUMOSIP LABORATORIOS ALPHA SAN IGNACIOP PHARMA tramitó un H2020: PneumoSIP project aims to be the first fully automated device in the POC market for the fast quantitative aetiological diagnose of Community-Acquired Pneumonia (CAP) also analysing antibiotic resistan...
2015-11-01 | Financiado
InForMed: An integrated pilot line for micro-fabricated medical devices PHILIPS ELECTRONICS NEDERLAND B.V. tramitó un FP6: The goal of the InForMed project is to establish an integrated pilot line for medical devices. The pilot line includes micro-fabrication, assembly and even the fabrication of smart catheters. The hear...
2015-06-01 | Financiado
PneumoSIP: PneumoSIP – a cost-effective solution for the rapid diagnostic of pneumonia LABORATORIOS ALPHA SAN IGNACIOP PHARMA tramitó un H2020: Despite significant advances in sanitation and medicine, infectious diseases still annually claim in excess of 15 million lives. Community acquired pneumonia (CAP) is a major cause of morbidity and mo...
2014-10-01 | Financiado
INCITE: Intelligent Catheters in Advanced Systems for Interventions PHILIPS ELECTRONICS NEDERLAND B.V. tramitó un FP6: INCITE aims to develop intelligent catheter technologies and systems that will accelerate the paradigm shift from costly, burdensome surgical treatments to cost-effective and patient-friendly minimall...
2014-03-01 | Financiado
PTQ-12-05805: Desarrollo de un biosensor multiplexado para el diagnóstico y vigilancia en enfermedades cardiovasculares LABORATORIOS ALPHA SAN IGNACIOP PHARMA tramitó un AEI: 2012-01-01 | Financiado
PTQ-11-04708: Biosensores de nanotubos de carbono: detección del marcador de enfermedad tromboembólica venosa D Dimero mediante anticuerpos inmovilizados. LABORATORIOS ALPHA SAN IGNACIOP PHARMA tramitó un AEI: 2011-01-01 | Financiado
PTQ-11-04851: Biosensor portátil para el diagnóstico de enfermedades cardiovasculares LABORATORIOS ALPHA SAN IGNACIOP PHARMA tramitó un AEI: 2011-01-01 | Financiado
INC-TU-2011-1253: Desarrollo de la electrónica, software y componentes mecánicos necesarios para la fabricación de un sistema de diagnóstico basado en electrodos interdigitados funcionalizados en condiciones de microf LABORATORIOS ALPHA SAN IGNACIOP PHARMA tramitó un AEI: 2011-01-01 | Financiado
IPT-2011-1337-010000: Nanotecnología para cardiología y neumococo (NanoCardioCoco) LABORATORIOS ALPHA SAN IGNACIOP PHARMA tramitó un AEI: 2011-01-01 | Financiado
CAJAL4EU: Chip Architectures by Joint Associated Labs for European Diagnostics NXP SEMICONDUCTORS BELGIUM NV tramitó un FP6: The main objective of the ENIAC JU project CAJAL4EU is to develop miniaturised biosensor technology platforms enabling diagnostic test manufacturers to build multi-parameter in-vitro test applications...
2010-03-01 | Financiado
PTQ-10-03449: Diseño de inmunosensores para la detección del D-dímero mediante anticuerpos inmovilizados sobre nanotubos de carbono LABORATORIOS ALPHA SAN IGNACIOP PHARMA tramitó un AEI: 2010-01-01 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.